InvestorsHub Logo
Followers 9
Posts 474
Boards Moderated 0
Alias Born 02/23/2017

Re: Poor Man - post# 462665

Tuesday, 04/26/2022 9:20:39 AM

Tuesday, April 26, 2022 9:20:39 AM

Post# of 687472
Sorry to disagree with you Poor Man but I don't agree with your theory. I've been an investor in this company since 2014 and I knew what I was getting into during those early days. I read alot of white papers on the subject and educated myself with the help of many on this board along with my due diligence on the subject. I am still far from any of the experts on this topic as expressed by those few on this board, but I do understand the very terrible disease of GBM. Now, here's the kicker, the fact that there are survivors of this disease living beyond three, four and five years is beyond astounding. Furthermore, all of these survivors are receivers of the DCVax-L vaccine. That alone is enough for me but there's more. The company is working, testing and progressing with their DCVax Direct vaccine which holds even greater results. Then throw in no side effects, low cost as result of flaskworks and just a follow up vaccine shot built from their own immune system is a dream from heaven. Who knows where this platform can lead us to next.

Yes, I am an investor in NWBO since 2014 and have been adding every year since then and I for one would never sell my investment at $10/shr. I truly hope that Linda P. can see this company through on their own helping all those with GBM and other solid tumors survive and rid themselves of these terrible diseases. Partnerships are good and will help this company thrive long into future developments of the DCVax platform immunotherapy science. Thank you for your time.

Hans
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News